{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T09:57:15Z","timestamp":1794477435201,"version":"4.9.1"},"reference-count":158,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl Neurodegener"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/2047-9158-3-10","type":"journal-article","created":{"date-parts":[[2014,5,9]],"date-time":"2014-05-09T23:02:35Z","timestamp":1399676555000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":41,"title":["Considerations on the role of environmental toxins in idiopathic Parkinson\u2019s disease pathophysiology"],"prefix":"10.1186","volume":"3","author":[{"given":"Francisco","family":"Pan-Montojo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heinz","family":"Reichmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,5,9]]},"reference":[{"key":"58_CR1","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1097\/00001648-199905000-00023","volume":"10","author":"H Checkoway","year":"1999","unstructured":"Checkoway H, Nelson LM: Epidemiologic approaches to the study of Parkinson\u2019s disease etiology. Epidemiology 1999, 10: 327-336. 10.1097\/00001648-199905000-00023","journal-title":"Epidemiology"},{"key":"58_CR2","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1002\/mds.10305","volume":"18","author":"D Twelves","year":"2003","unstructured":"Twelves D, Perkins KS, Counsell C: Systematic review of incidence studies of Parkinson\u2019s disease. Mov Disord 2003, 18: 19-31. 10.1002\/mds.10305","journal-title":"Mov Disord"},{"key":"58_CR3","first-page":"S21","volume":"54","author":"MC de Rijk","year":"2000","unstructured":"de Rijk MC, Launer LJ, Berger K, Breteler MM, Dartigues JF, Baldereschi M, Fratiglioni L, Lobo A, Martinez-Lage J, Trenkwalder C, Hofman A: Prevalence of Parkinson\u2019s disease in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. Neurology 2000, 54: S21-S23.","journal-title":"Neurology"},{"key":"58_CR4","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1034\/j.1399-0004.1998.5440401.x","volume":"54","author":"T Gasser","year":"1998","unstructured":"Gasser T: Genetics of Parkinson\u2019s disease. Clin Genet 1998, 54: 259-265. 10.1034\/j.1399-0004.1998.5440401.x","journal-title":"Clin Genet"},{"key":"58_CR5","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1177\/0891988710383572","volume":"23","author":"LM Bekris","year":"2010","unstructured":"Bekris LM, Mata IF, Zabetian CP: The genetics of Parkinson disease. J Geriatr Psychiatry Neurol 2010, 23: 228-242. 10.1177\/0891988710383572","journal-title":"J Geriatr Psychiatry Neurol"},{"key":"58_CR6","first-page":"55","volume":"6","author":"Y Ben-Shlomo","year":"1997","unstructured":"Ben-Shlomo Y: The epidemiology of Parkinson\u2019s disease. Baillieres Clin Neurol 1997, 6: 55-68.","journal-title":"Baillieres Clin Neurol"},{"key":"58_CR7","first-page":"153","volume":"80","author":"CM Tanner","year":"1999","unstructured":"Tanner CM, Ben-Shlomo Y: Epidemiology of Parkinson\u2019s disease. Adv Neurol 1999, 80: 153-159.","journal-title":"Adv Neurol"},{"key":"58_CR8","doi-asserted-by":"publisher","first-page":"238","DOI":"10.2169\/internalmedicine.35.238","volume":"35","author":"K Kondo","year":"1996","unstructured":"Kondo K: Rising prevalence of neurodegenerative diseases worldwide. Intern Med 1996, 35: 238. 10.2169\/internalmedicine.35.238","journal-title":"Intern Med"},{"key":"58_CR9","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1159\/000071194","volume":"22","author":"I Baldi","year":"2003","unstructured":"Baldi I, Cantagrel A, Lebailly P, Tison F, Dubroca B, Chrysostome V, Dartigues JF, Brochard P: Association between Parkinson\u2019s disease and exposure to pesticides in southwestern France. Neuroepidemiology 2003, 22: 305-310. 10.1159\/000071194","journal-title":"Neuroepidemiology"},{"key":"58_CR10","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1016\/j.neuro.2012.05.011","volume":"33","author":"C Freire","year":"2012","unstructured":"Freire C, Koifman S: Pesticide exposure and Parkinson\u2019s disease: epidemiological evidence of association. Neurotoxicology 2012, 33: 947-971. 10.1016\/j.neuro.2012.05.011","journal-title":"Neurotoxicology"},{"key":"58_CR11","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1212\/WNL.50.5.1346","volume":"50","author":"JM Gorell","year":"1998","unstructured":"Gorell JM, Johnson CC, Rybicki BA, Peterson EL, Richardson RJ: The risk of Parkinson\u2019s disease with exposure to pesticides, farming, well water, and rural living. Neurology 1998, 50: 1346-1350. 10.1212\/WNL.50.5.1346","journal-title":"Neurology"},{"key":"58_CR12","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1177\/014107689108400814","volume":"84","author":"M Gourie-Devi","year":"1991","unstructured":"Gourie-Devi M, Ramu MG, Venkataram BS: Treatment of Parkinson\u2019s disease in \u2018Ayurveda\u2019 (ancient Indian system of medicine): discussion paper. J R Soc Med 1991, 84: 491-492.","journal-title":"J R Soc Med"},{"key":"58_CR13","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1001\/archneur.63.5.782","volume":"63","author":"ZX Zhang","year":"2006","unstructured":"Zhang ZX, Dong ZH, Roman GC: Early descriptions of Parkinson disease in ancient China. Arch Neurol 2006, 63: 782-784. 10.1001\/archneur.63.5.782","journal-title":"Arch Neurol"},{"key":"58_CR14","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1016\/S0140-6736(83)90802-4","volume":"2","author":"DB Calne","year":"1983","unstructured":"Calne DB, Langston JW: Aetiology of Parkinson\u2019s disease. Lancet 1983, 2: 1457-1459.","journal-title":"Lancet"},{"key":"58_CR15","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/S1474-4422(06)70471-9","volume":"5","author":"LM de Lau","year":"2006","unstructured":"de Lau LM, Breteler MM: Epidemiology of Parkinson\u2019s disease. Lancet Neurol 2006, 5: 525-535. 10.1016\/S1474-4422(06)70471-9","journal-title":"Lancet Neurol"},{"key":"58_CR16","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.jns.2012.05.030","volume":"322","author":"A Federico","year":"2012","unstructured":"Federico A, Cardaioli E, Da Pozzo P, Formichi P, Gallus GN, Radi E: Mitochondria, oxidative stress and neurodegeneration. J Neurol Sci 2012, 322: 254-262. 10.1016\/j.jns.2012.05.030","journal-title":"J Neurol Sci"},{"key":"58_CR17","volume-title":"Book Methods Protocol for the Human Mortality Database","author":"JR Wilmoth","year":"2002","unstructured":"Wilmoth JR: Methods protocol for the human mortality database. Book Methods Protocol for the Human Mortality Database 2002. (Editor ed.^eds.). City"},{"key":"58_CR18","first-page":"5","volume":"1","author":"FJAPP Goerlich Gisbert","year":"2006","unstructured":"Goerlich Gisbert FJAPP: Esperanza de vida en Espa\u00f1a a lo largo del siglo XX. BBVA 2006, 1: 5-43.","journal-title":"BBVA"},{"key":"58_CR19","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1093\/aje\/kwk024","volume":"165","author":"F Kamel","year":"2007","unstructured":"Kamel F, Tanner C, Umbach D, Hoppin J, Alavanja M, Blair A, Comyns K, Goldman S, Korell M, Langston J, Ross G, Sandler D: Pesticide exposure and self-reported Parkinson\u2019s disease in the agricultural health study. Am J Epidemiol 2007, 165: 364-374.","journal-title":"Am J Epidemiol"},{"key":"58_CR20","first-page":"1","volume":"35","author":"RO Ranga Rao GV","year":"2007","unstructured":"Ranga Rao GV RO, Rameshwar Rao V, Reddy YVR: Role of biopesticides in crop protection: present status and future prospects. Indian J Plant Prot 2007, 35: 1-9.","journal-title":"Indian J Plant Prot"},{"key":"58_CR21","volume-title":"Organic Insecticides: Their Chemistry and Mode of Action","author":"RL Metcalf","year":"1955","unstructured":"Metcalf RL: Organic Insecticides: Their Chemistry and Mode of Action. New York: Interscience Publishers, Inc.; 1955."},{"key":"58_CR22","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1212\/WNL.48.6.1583","volume":"48","author":"HH Liou","year":"1997","unstructured":"Liou HH, Tsai MC, Chen CJ, Jeng JS, Chang YC, Chen SY, Chen RC: Environmental risk factors and Parkinson\u2019s disease: a case-control study in Taiwan. Neurology 1997, 48: 1583-1588. 10.1212\/WNL.48.6.1583","journal-title":"Neurology"},{"key":"58_CR23","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1006\/enrs.2001.4264","volume":"86","author":"A Priyadarshi","year":"2001","unstructured":"Priyadarshi A, Khuder SA, Schaub EA, Priyadarshi SS: Environmental risk factors and Parkinson\u2019s disease: a metaanalysis. Environ Res 2001, 86: 122-127. 10.1006\/enrs.2001.4264","journal-title":"Environ Res"},{"key":"58_CR24","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/S1353-8020(01)00054-2","volume":"8","author":"BC Lai","year":"2002","unstructured":"Lai BC, Marion SA, Teschke K, Tsui JK: Occupational and environmental risk factors for Parkinson\u2019s disease. Parkinsonism Relat Disord 2002, 8: 297-309. 10.1016\/S1353-8020(01)00054-2","journal-title":"Parkinsonism Relat Disord"},{"key":"58_CR25","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1017\/S0317167100036635","volume":"13","author":"AH Rajput","year":"1986","unstructured":"Rajput AH, Uitti RJ, Stern W, Laverty W: Early onset Parkinson\u2019s disease in Saskatchewan\u2013environmental considerations for etiology. Can J Neurol Sci 1986, 13: 312-316.","journal-title":"Can J Neurol Sci"},{"key":"58_CR26","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/S0022-510X(01)00578-0","volume":"190","author":"M Behari","year":"2001","unstructured":"Behari M, Srivastava AK, Das RR, Pandey RM: Risk factors of Parkinson\u2019s disease in Indian patients. J Neurol Sci 2001, 190: 49-55. 10.1016\/S0022-510X(01)00578-0","journal-title":"J Neurol Sci"},{"key":"58_CR27","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1212\/WNL.46.5.1275","volume":"46","author":"A Seidler","year":"1996","unstructured":"Seidler A, Hellenbrand W, Robra BP, Vieregge P, Nischan P, Joerg J, Oertel WH, Ulm G, Schneider E: Possible environmental, occupational, and other etiologic factors for Parkinson\u2019s disease: a case-control study in Germany. Neurology 1996, 46: 1275-1284. 10.1212\/WNL.46.5.1275","journal-title":"Neurology"},{"key":"58_CR28","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1212\/WNL.42.7.1328","volume":"42","author":"KM Semchuk","year":"1992","unstructured":"Semchuk KM, Love EJ, Lee RG: Parkinson\u2019s disease and exposure to agricultural work and pesticide chemicals. Neurology 1992, 42: 1328-1335. 10.1212\/WNL.42.7.1328","journal-title":"Neurology"},{"key":"58_CR29","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1002\/ana.410360119","volume":"36","author":"L Fleming","year":"1994","unstructured":"Fleming L, Mann JB, Bean J, Briggle T, Sanchez-Ramos JR: Parkinson\u2019s disease and brain levels of organochlorine pesticides. Ann Neurol 1994, 36: 100-103. 10.1002\/ana.410360119","journal-title":"Ann Neurol"},{"key":"58_CR30","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1289\/ehp.1002839","volume":"119","author":"CM Tanner","year":"2011","unstructured":"Tanner CM, Kamel F, Ross GW, Hoppin JA, Goldman SM, Korell M, Marras C, Bhudhikanok GS, Kasten M, Chade AR, Comyns K, Richards MB, Meng C, Priestley B, Fernandez HH, Cambi F, Umbach DM, Blair A, Sandler DP, Langston JW: Rotenone, paraquat, and Parkinson\u2019s disease. Environ Health Perspect 2011, 119: 866-872. 10.1289\/ehp.1002839","journal-title":"Environ Health Perspect"},{"key":"58_CR31","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1046\/j.1471-4159.2003.02138.x","volume":"88","author":"P Champy","year":"2004","unstructured":"Champy P, Hoglinger GU, Feger J, Gleye C, Hocquemiller R, Laurens A, Guerineau V, Laprevote O, Medja F, Lombes A, Michel PP, Lannuzel A, Hirsch EC, Ruberg M: Annonacin, a lipophilic inhibitor of mitochondrial complex I, induces nigral and striatal neurodegeneration in rats: possible relevance for atypical parkinsonism in Guadeloupe. J Neurochem 2004, 88: 63-69.","journal-title":"J Neurochem"},{"key":"58_CR32","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1212\/WNL.43.8.1479","volume":"43","author":"CC Huang","year":"1993","unstructured":"Huang CC, Lu CS, Chu NS, Hochberg F, Lilienfeld D, Olanow W, Calne DB: Progression after chronic manganese exposure. Neurology 1993, 43: 1479-1483. 10.1212\/WNL.43.8.1479","journal-title":"Neurology"},{"key":"58_CR33","first-page":"15","volume-title":"New York Times","author":"H Needleman","year":"1996","unstructured":"Needleman H, Landrigan PJ: Toxins at the pump. New York Times 1996, 15."},{"key":"58_CR34","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1016\/j.neuro.2011.04.002","volume":"32","author":"JR Richardson","year":"2011","unstructured":"Richardson JR, Roy A, Shalat SL, Buckley B, Winnik B, Gearing M, Levey AI, Factor SA, O\u2019Suilleabhain P, German DC: Beta-hexachlorocyclohexane levels in serum and risk of Parkinson\u2019s disease. Neurotoxicology 2011, 32: 640-645. 10.1016\/j.neuro.2011.04.002","journal-title":"Neurotoxicology"},{"key":"58_CR35","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/S0378-8741(02)00170-8","volume":"82","author":"DM Brownson","year":"2002","unstructured":"Brownson DM, Mabry TJ, Leslie SW: The cycad neurotoxic amino acid, beta-N-methylamino-L-alanine (BMAA), elevates intracellular calcium levels in dissociated rat brain cells. J Ethnopharmacol 2002, 82: 159-167. 10.1016\/S0378-8741(02)00170-8","journal-title":"J Ethnopharmacol"},{"key":"58_CR36","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1002\/nt.2620030411","volume":"3","author":"AA Seawright","year":"1995","unstructured":"Seawright AA: Directly toxic effects of plant chemicals which may occur in human and animal foods. Nat Toxins 1995, 3: 227-232. discussion 242 10.1002\/nt.2620030411","journal-title":"Nat Toxins"},{"issue":"Suppl 2","key":"58_CR37","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3109\/17482960903286009","volume":"10","author":"WG Bradley","year":"2009","unstructured":"Bradley WG, Mash DC: Beyond Guam: the cyanobacteria\/BMAA hypothesis of the cause of ALS and other neurodegenerative diseases. Amyotroph Lateral Scler 2009, 10(Suppl 2):7-20.","journal-title":"Amyotroph Lateral Scler"},{"key":"58_CR38","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1212\/WNL.4.6.438","volume":"4","author":"LT Kurland","year":"1954","unstructured":"Kurland LT, Mulder DW: Epidemiologic investigations of amyotrophic lateral sclerosis. I. Preliminary report on geographic distribution and special reference to the Mariana Islands, including clinical and pathologic observations. Neurology 1954, 4: 438-448. 10.1212\/WNL.4.6.438","journal-title":"Neurology"},{"key":"58_CR39","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1093\/aje\/kwf175","volume":"157","author":"CC Plato","year":"2003","unstructured":"Plato CC, Garruto RM, Galasko D, Craig UK, Plato M, Gamst A, Torres JM, Wiederholt W: Amyotrophic lateral sclerosis and parkinsonism-dementia complex of Guam: changing incidence rates during the past 60\u00a0years. Am J Epidemiol 2003, 157: 149-157. 10.1093\/aje\/kwf175","journal-title":"Am J Epidemiol"},{"key":"58_CR40","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1136\/jnnp.66.3.380","volume":"66","author":"M Doder","year":"1999","unstructured":"Doder M, Jahanshahi M, Turjanski N, Moseley IF, Lees AJ: Parkinson\u2019s syndrome after closed head injury: a single case report. J Neurol Neurosurg Psychiatry 1999, 66: 380-385. 10.1136\/jnnp.66.3.380","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"58_CR41","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/0090-3019(85)90035-7","volume":"24","author":"T Nayernouri","year":"1985","unstructured":"Nayernouri T: Posttraumatic parkinsonism. Surg Neurol 1985, 24: 263-264. 10.1016\/0090-3019(85)90035-7","journal-title":"Surg Neurol"},{"key":"58_CR42","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1002\/ana.20882","volume":"60","author":"SM Goldman","year":"2006","unstructured":"Goldman SM, Tanner CM, Oakes D, Bhudhikanok GS, Gupta A, Langston JW: Head injury and Parkinson\u2019s disease risk in twins. Ann Neurol 2006, 60: 65-72. 10.1002\/ana.20882","journal-title":"Ann Neurol"},{"key":"58_CR43","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1002\/mds.25458","volume":"28","author":"S Jafari","year":"2013","unstructured":"Jafari S, Etminan M, Aminzadeh F, Samii A: Head injury and risk of Parkinson disease: a systematic review and meta-analysis. Mov Disord 2013, 28: 1222-1229. 10.1002\/mds.25458","journal-title":"Mov Disord"},{"key":"58_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1124\/jpet.102.035048","volume":"304","author":"B Liu","year":"2003","unstructured":"Liu B, Hong JS: Role of microglia in inflammation-mediated neurodegenerative diseases: mechanisms and strategies for therapeutic intervention. J Pharmacol Exp Ther 2003, 304: 1-7. 10.1124\/jpet.102.035048","journal-title":"J Pharmacol Exp Ther"},{"key":"58_CR45","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1007\/s007020070018","volume":"107","author":"M Ghaemi","year":"2000","unstructured":"Ghaemi M, Rudolf J, Schmulling S, Bamborschke S, Heiss WD: FDG- and Dopa-PET in postencephalitic parkinsonism. J Neural Transm 2000, 107: 1289-1295. 10.1007\/s007020070018","journal-title":"J Neural Transm"},{"key":"58_CR46","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1212\/WNL.57.3.456","volume":"57","author":"RD Abbott","year":"2001","unstructured":"Abbott RD, Petrovitch H, White LR, Masaki KH, Tanner CM, Curb JD, Grandinetti A, Blanchette PL, Popper JS, Ross GW: Frequency of bowel movements and the future risk of Parkinson\u2019s disease. Neurology 2001, 57: 456-462. 10.1212\/WNL.57.3.456","journal-title":"Neurology"},{"key":"58_CR47","first-page":"1","volume":"20","author":"G Selby","year":"1984","unstructured":"Selby G: The Graeme Robertson memorial lecture, 1983. The long-term prognosis of Parkinson\u2019s disease. Clin Exp Neurol 1984, 20: 1-25.","journal-title":"Clin Exp Neurol"},{"key":"58_CR48","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1212\/WNL.36.11.1490","volume":"36","author":"JA Baron","year":"1986","unstructured":"Baron JA: Cigarette smoking and Parkinson\u2019s disease. Neurology 1986, 36: 1490-1496. 10.1212\/WNL.36.11.1490","journal-title":"Neurology"},{"key":"58_CR49","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1002\/ana.1052","volume":"50","author":"A Ascherio","year":"2001","unstructured":"Ascherio A, Zhang SM, Hernan MA, Kawachi I, Colditz GA, Speizer FE, Willett WC: Prospective study of caffeine consumption and risk of Parkinson\u2019s disease in men and women. Ann Neurol 2001, 50: 56-63. 10.1002\/ana.1052","journal-title":"Ann Neurol"},{"key":"58_CR50","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1093\/aje\/kwm127","volume":"166","author":"MG Weisskopf","year":"2007","unstructured":"Weisskopf MG, O\u2019Reilly E, Chen H, Schwarzschild MA, Ascherio A: Plasma urate and risk of Parkinson\u2019s disease. Am J Epidemiol 2007, 166: 561-567. 10.1093\/aje\/kwm127","journal-title":"Am J Epidemiol"},{"key":"58_CR51","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1097\/00005072-199603000-00001","volume":"55","author":"LS Forno","year":"1996","unstructured":"Forno LS: Neuropathology of Parkinson\u2019s disease. J Neuropathol Exp Neurol 1996, 55: 259-272. 10.1097\/00005072-199603000-00001","journal-title":"J Neuropathol Exp Neurol"},{"key":"58_CR52","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/42166","volume":"388","author":"MG Spillantini","year":"1997","unstructured":"Spillantini MG, Schmidt ML, Lee VM, Trojanowski JQ, Jakes R, Goedert M: Alpha-synuclein in Lewy bodies. Nature 1997, 388: 839-840. 10.1038\/42166","journal-title":"Nature"},{"key":"58_CR53","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","volume":"24","author":"H Braak","year":"2003","unstructured":"Braak H, Del Tredici K, Rub U, de Vos RA, Jansen Steur EN, Braak E: Staging of brain pathology related to sporadic Parkinson\u2019s disease. Neurobiol Aging 2003, 24: 197-211. 10.1016\/S0197-4580(02)00065-9","journal-title":"Neurobiol Aging"},{"key":"58_CR54","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s00441-004-0956-9","volume":"318","author":"H Braak","year":"2004","unstructured":"Braak H, Ghebremedhin E, Rub U, Bratzke H, Del Tredici K: Stages in the development of Parkinson\u2019s disease-related pathology. Cell Tissue Res 2004, 318: 121-134. 10.1007\/s00441-004-0956-9","journal-title":"Cell Tissue Res"},{"issue":"Suppl 2","key":"58_CR55","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1159\/000113469","volume":"38","author":"K Wakabayashi","year":"1997","unstructured":"Wakabayashi K, Takahashi H: Neuropathology of autonomic nervous system in Parkinson\u2019s disease. Eur Neurol 1997, 38(Suppl 2):2-7.","journal-title":"Eur Neurol"},{"key":"58_CR56","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.neulet.2005.11.012","volume":"396","author":"H Braak","year":"2006","unstructured":"Braak H, de Vos RA, Bohl J, Del Tredici K: Gastric alpha-synuclein immunoreactive inclusions in Meissner\u2019s and Auerbach\u2019s plexuses in cases staged for Parkinson\u2019s disease-related brain pathology. Neurosci Lett 2006, 396: 67-72. 10.1016\/j.neulet.2005.11.012","journal-title":"Neurosci Lett"},{"key":"58_CR57","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1007\/s00401-010-0665-2","volume":"119","author":"K Del Tredici","year":"2010","unstructured":"Del Tredici K, Hawkes CH, Ghebremedhin E, Braak H: Lewy pathology in the submandibular gland of individuals with incidental Lewy body disease and sporadic Parkinson\u2019s disease. Acta Neuropathol 2010, 119: 703-713. 10.1007\/s00401-010-0665-2","journal-title":"Acta Neuropathol"},{"key":"58_CR58","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1007\/s00401-005-0995-7","volume":"109","author":"S Orimo","year":"2005","unstructured":"Orimo S, Amino T, Itoh Y, Takahashi A, Kojo T, Uchihara T, Tsuchiya K, Mori F, Wakabayashi K, Takahashi H: Cardiac sympathetic denervation precedes neuronal loss in the sympathetic ganglia in Lewy body disease. Acta Neuropathol 2005, 109: 583-588. 10.1007\/s00401-005-0995-7","journal-title":"Acta Neuropathol"},{"key":"58_CR59","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1002\/mds.1099","volume":"16","author":"LM Shulman","year":"2001","unstructured":"Shulman LM, Taback RL, Bean J, Weiner WJ: Comorbidity of the nonmotor symptoms of Parkinson\u2019s disease. Mov Disord 2001, 16: 507-510. 10.1002\/mds.1099","journal-title":"Mov Disord"},{"issue":"Suppl 2","key":"58_CR60","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1111\/j.1468-1331.2008.02212.x","volume":"15","author":"KR Chaudhuri","year":"2008","unstructured":"Chaudhuri KR, Martinez-Martin P: Quantitation of non-motor symptoms in Parkinson\u2019s disease. Eur J Neurol 2008, 15(Suppl 2):2-7.","journal-title":"Eur J Neurol"},{"key":"58_CR61","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1002\/mds.21413","volume":"22","author":"A Haehner","year":"2007","unstructured":"Haehner A, Hummel T, Hummel C, Sommer U, Junghanns S, Reichmann H: Olfactory loss may be a first sign of idiopathic Parkinson\u2019s disease. Mov Disord 2007, 22: 839-842. 10.1002\/mds.21413","journal-title":"Mov Disord"},{"key":"58_CR62","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1002\/mds.20141","volume":"19","author":"U Sommer","year":"2004","unstructured":"Sommer U, Hummel T, Cormann K, Mueller A, Frasnelli J, Kropp J, Reichmann H: Detection of presymptomatic Parkinson\u2019s disease: combining smell tests, transcranial sonography, and SPECT. Mov Disord 2004, 19: 1196-1202. 10.1002\/mds.20141","journal-title":"Mov Disord"},{"key":"58_CR63","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1136\/jnnp.2009.183715","volume":"81","author":"MM Ponsen","year":"2010","unstructured":"Ponsen MM, Stoffers D, Wolters E, Booij J, Berendse HW: Olfactory testing combined with dopamine transporter imaging as a method to detect prodromal Parkinson\u2019s disease. J Neurol Neurosurg Psychiatry 2010, 81: 396-399. 10.1136\/jnnp.2009.183715","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"58_CR64","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1093\/brain\/awh322","volume":"128","author":"K Stiasny-Kolster","year":"2005","unstructured":"Stiasny-Kolster K, Doerr Y, Moller JC, Hoffken H, Behr TM, Oertel WH, Mayer G: Combination of \u2018idiopathic\u2019 REM sleep behaviour disorder and olfactory dysfunction as possible indicator for alpha-synucleinopathy demonstrated by dopamine transporter FP-CIT-SPECT. Brain: a j neurol 2005, 128: 126-137.","journal-title":"Brain: a j neurol"},{"key":"58_CR65","volume-title":"Diseases of the nervous system","author":"W Gowers","year":"1888","unstructured":"Gowers W: Diseases of the nervous system. London: Chapman; 1888."},{"key":"58_CR66","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1002\/ana.410360417","volume":"36","author":"H Payami","year":"1994","unstructured":"Payami H, Larsen K, Bernard S, Nutt J: Increased risk of Parkinson\u2019s disease in parents and siblings of patients. Ann Neurol 1994, 36: 659-661. 10.1002\/ana.410360417","journal-title":"Ann Neurol"},{"key":"58_CR67","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1017\/S0317167100039469","volume":"22","author":"V Bonifati","year":"1995","unstructured":"Bonifati V, Fabrizio E, Vanacore N, De Mari M, Meco G: Familial Parkinson\u2019s disease: a clinical genetic analysis. Can J Neurol Sci 1995, 22: 272-279.","journal-title":"Can J Neurol Sci"},{"key":"58_CR68","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1002\/ana.410370525","volume":"37","author":"P Vieregge","year":"1995","unstructured":"Vieregge P, Heberlein I: Increased risk of Parkinson\u2019s disease in relatives of patients. Ann Neurol 1995, 37: 685.","journal-title":"Ann Neurol"},{"key":"58_CR69","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1002\/mds.870110105","volume":"11","author":"G De Michele","year":"1996","unstructured":"De Michele G, Filla A, Volpe G, De Marco V, Gogliettino A, Ambrosio G, Marconi R, Castellano AE, Campanella G: Environmental and genetic risk factors in Parkinson\u2019s disease: a case-control study in southern Italy. Mov Disord 1996, 11: 17-23. 10.1002\/mds.870110105","journal-title":"Mov Disord"},{"key":"58_CR70","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1212\/WNL.47.1.155","volume":"47","author":"K Marder","year":"1996","unstructured":"Marder K, Tang MX, Mejia H, Alfaro B, Cote L, Louis E, Groves J, Mayeux R: Risk of Parkinson\u2019s disease among first-degree relatives: A community-based study. Neurology 1996, 47: 155-160. 10.1212\/WNL.47.1.155","journal-title":"Neurology"},{"key":"58_CR71","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1001\/jama.281.4.341","volume":"281","author":"CM Tanner","year":"1999","unstructured":"Tanner CM, Ottman R, Goldman SM, Ellenberg J, Chan P, Mayeux R, Langston JW: Parkinson disease in twins: an etiologic study. JAMA 1999, 281: 341-346. 10.1001\/jama.281.4.341","journal-title":"JAMA"},{"key":"58_CR72","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","volume":"276","author":"MH Polymeropoulos","year":"1997","unstructured":"Polymeropoulos MH, Lavedan C, Leroy E, Ide SE, Dehejia A, Dutra A, Pike B, Root H, Rubenstein J, Boyer R, Stenroos ES, Chandrasekharappa S, Athanassiadou A, Papapetropoulos T, Johnson WG, Lazzarini AM, Duvoisin RC, Di Iorio G, Golbe LI, Nussbaum RL: Mutation in the alpha-synuclein gene identified in families with Parkinson\u2019s disease. Science 1997, 276: 2045-2047. 10.1126\/science.276.5321.2045","journal-title":"Science"},{"key":"58_CR73","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1126\/science.1090278","volume":"302","author":"AB Singleton","year":"2003","unstructured":"Singleton AB, Farrer M, Johnson J, Singleton A, Hague S, Kachergus J, Hulihan M, Peuralinna T, Dutra A, Nussbaum R, Lincoln S, Crawley A, Hanson M, Maraganore D, Adler C, Cookson MR, Muenter M, Baptista M, Miller D, Blancato J, Hardy J, Gwinn-Hardy K: Alpha-Synuclein locus triplication causes Parkinson\u2019s disease. Science 2003, 302: 841. 10.1126\/science.1090278","journal-title":"Science"},{"key":"58_CR74","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1038\/33416","volume":"392","author":"T Kitada","year":"1998","unstructured":"Kitada T, Asakawa S, Hattori N, Matsumine H, Yamamura Y, Minoshima S, Yokochi M, Mizuno Y, Shimizu N: Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature 1998, 392: 605-608. 10.1038\/33416","journal-title":"Nature"},{"key":"58_CR75","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1007\/s004390050845","volume":"103","author":"E Leroy","year":"1998","unstructured":"Leroy E, Anastasopoulos D, Konitsiotis S, Lavedan C, Polymeropoulos MH: Deletions in the Parkin gene and genetic heterogeneity in a Greek family with early onset Parkinson\u2019s disease. Hum Genet 1998, 103: 424-427. 10.1007\/s004390050845","journal-title":"Hum Genet"},{"key":"58_CR76","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1002\/ana.20256","volume":"56","author":"EM Valente","year":"2004","unstructured":"Valente EM, Salvi S, Ialongo T, Marongiu R, Elia AE, Caputo V, Romito L, Albanese A, Dallapiccola B, Bentivoglio AR: PINK1 mutations are associated with sporadic early-onset parkinsonism. Ann Neurol 2004, 56: 336-341. 10.1002\/ana.20256","journal-title":"Ann Neurol"},{"key":"58_CR77","first-page":"410","volume":"365","author":"WC Nichols","year":"2005","unstructured":"Nichols WC, Pankratz N, Hernandez D, Paisan-Ruiz C, Jain S, Halter CA, Michaels VE, Reed T, Rudolph A, Shults CW, Singleton A, Foroud T: Genetic screening for a single common LRRK2 mutation in familial Parkinson\u2019s disease. Lancet 2005, 365: 410-412.","journal-title":"Lancet"},{"key":"58_CR78","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1002\/ana.10324","volume":"52","author":"AA Hicks","year":"2002","unstructured":"Hicks AA, Petursson H, Jonsson T, Stefansson H, Johannsdottir HS, Sainz J, Frigge ML, Kong A, Gulcher JR, Stefansson K, Sveinbjornsdottir S: A susceptibility gene for late-onset idiopathic Parkinson\u2019s disease. Ann Neurol 2002, 52: 549-555. 10.1002\/ana.10324","journal-title":"Ann Neurol"},{"key":"58_CR79","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1086\/374383","volume":"72","author":"N Pankratz","year":"2003","unstructured":"Pankratz N, Nichols WC, Uniacke SK, Halter C, Rudolph A, Shults C, Conneally PM, Foroud T: Significant linkage of Parkinson disease to chromosome 2q36-37. Am J Hum Genet 2003, 72: 1053-1057. 10.1086\/374383","journal-title":"Am J Hum Genet"},{"key":"58_CR80","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1093\/hmg\/ddg134","volume":"12","author":"FP Marx","year":"2003","unstructured":"Marx FP, Holzmann C, Strauss KM, Li L, Eberhardt O, Gerhardt E, Cookson MR, Hernandez D, Farrer MJ, Kachergus J, Engelender S, Ross CA, Berger K, Schols L, Schulz JB, Riess O, Kruger R: Identification and functional characterization of a novel R621C mutation in the synphilin-1 gene in Parkinson\u2019s disease. Hum Mol Genet 2003, 12: 1223-1231. 10.1093\/hmg\/ddg134","journal-title":"Hum Mol Genet"},{"key":"58_CR81","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/ng1066","volume":"33","author":"WD Le","year":"2003","unstructured":"Le WD, Xu P, Jankovic J, Jiang H, Appel SH, Smith RG, Vassilatis DK: Mutations in NR4A2 associated with familial Parkinson disease. Nat Genet 2003, 33: 85-89.","journal-title":"Nat Genet"},{"key":"58_CR82","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.neuron.2004.10.023","volume":"44","author":"C Paisan-Ruiz","year":"2004","unstructured":"Paisan-Ruiz C, Jain S, Evans EW, Gilks WP, Simon J, van der Brug M, Lopez De Munain A, Aparicio S, Gil AM, Khan N, Johnson J, Martinez JR, Nicholl D, Carrera IM, Pena AS, de Silva R, Lees A, Marti-Masso JF, Perez-Tur J, Wood NW, Singleton AB: Cloning of the gene containing mutations that cause PARK8-linked Parkinson\u2019s disease. Neuron 2004, 44: 595-600. 10.1016\/j.neuron.2004.10.023","journal-title":"Neuron"},{"key":"58_CR83","doi-asserted-by":"publisher","first-page":"e1002548","DOI":"10.1371\/journal.pgen.1002548","volume":"8","author":"CM Lill","year":"2012","unstructured":"Lill CM, Roehr JT, McQueen MB, Kavvoura FK, Bagade S, Schjeide BM, Schjeide LM, Meissner E, Zauft U, Allen NC, Liu T, Schilling M, Anderson KJ, Beecham G, Berg D, Biernacka JM, Brice A, DeStefano AL, Do CB, Eriksson N, Factor SA, Farrer MJ, Foroud T, Gasser T, Hamza T, Hardy JA, Heutink P, Hill-Burns EM, Klein C, Latourelle JC, et al.: Comprehensive research synopsis and systematic meta-analyses in Parkinson\u2019s disease genetics: The PDGene database. PLoS Genet 2012, 8: e1002548. 10.1371\/journal.pgen.1002548","journal-title":"PLoS Genet"},{"key":"58_CR84","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1146\/annurev.neuro.28.061604.135718","volume":"28","author":"DJ Moore","year":"2005","unstructured":"Moore DJ, West AB, Dawson VL, Dawson TM: Molecular pathophysiology of Parkinson\u2019s disease. Annu Rev Neurosci 2005, 28: 57-87. 10.1146\/annurev.neuro.28.061604.135718","journal-title":"Annu Rev Neurosci"},{"key":"58_CR85","doi-asserted-by":"publisher","first-page":"a009324","DOI":"10.1101\/cshperspect.a009324","volume":"2","author":"Y Lee","year":"2012","unstructured":"Lee Y, Dawson VL, Dawson TM: Animal models of Parkinson\u2019s disease: vertebrate genetics. Cold Spring Harb Perspect Med 2012, 2: a009324.","journal-title":"Cold Spring Harb Perspect Med"},{"key":"58_CR86","doi-asserted-by":"publisher","first-page":"3571","DOI":"10.1038\/emboj.2010.223","volume":"29","author":"F Kamp","year":"2010","unstructured":"Kamp F, Exner N, Lutz AK, Wender N, Hegermann J, Brunner B, Nuscher B, Bartels T, Giese A, Beyer K, Eimer S, Winklhofer KF, Haass C: Inhibition of mitochondrial fusion by alpha-synuclein is rescued by PINK1, Parkin and DJ-1. Embo J 2010, 29: 3571-3589. 10.1038\/emboj.2010.223","journal-title":"Embo J"},{"key":"58_CR87","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1038\/35006074","volume":"404","author":"MB Feany","year":"2000","unstructured":"Feany MB, Bender WW: A Drosophila model of Parkinson\u2019s disease. Nature 2000, 404: 394-398. 10.1038\/35006074","journal-title":"Nature"},{"key":"58_CR88","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.1111\/j.1471-4159.2008.05463.x","volume":"106","author":"L Flinn","year":"2008","unstructured":"Flinn L, Bretaud S, Lo C, Ingham PW, Bandmann O: Zebrafish as a new animal model for movement disorders. J Neurochem 2008, 106: 1991-1997. 10.1111\/j.1471-4159.2008.05463.x","journal-title":"J Neurochem"},{"key":"58_CR89","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1038\/nature04779","volume":"441","author":"IE Clark","year":"2006","unstructured":"Clark IE, Dodson MW, Jiang C, Cao JH, Huh JR, Seol JH, Yoo SJ, Hay BA, Guo M: Drosophila pink1 is required for mitochondrial function and interacts genetically with parkin. Nature 2006, 441: 1162-1166. 10.1038\/nature04779","journal-title":"Nature"},{"key":"58_CR90","doi-asserted-by":"publisher","first-page":"24065","DOI":"10.1074\/jbc.M002413200","volume":"275","author":"CA da Costa","year":"2000","unstructured":"da Costa CA, Ancolio K, Checler F: Wild-type but not Parkinson\u2019s disease-related ala-53 Thr mutant alpha -synuclein protects neuronal cells from apoptotic stimuli. The J biol chem 2000, 275: 24065-24069. 10.1074\/jbc.M002413200","journal-title":"The J biol chem"},{"key":"58_CR91","doi-asserted-by":"publisher","first-page":"7502","DOI":"10.1523\/JNEUROSCI.0096-06.2006","volume":"26","author":"Y Leng","year":"2006","unstructured":"Leng Y, Chuang DM: Endogenous alpha-synuclein is induced by valproic acid through histone deacetylase inhibition and participates in neuroprotection against glutamate-induced excitotoxicity. J Neurosci 2006, 26: 7502-7512. 10.1523\/JNEUROSCI.0096-06.2006","journal-title":"J Neurosci"},{"key":"58_CR92","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/s12035-012-8291-8","volume":"46","author":"S Yadav","year":"2012","unstructured":"Yadav S, Dixit A, Agrawal S, Singh A, Srivastava G, Singh AK, Srivastava PK, Prakash O, Singh MP: Rodent models and contemporary molecular techniques: notable feats yet incomplete explanations of Parkinson\u2019s disease pathogenesis. Mol Neurobiol 2012, 46: 495-512. 10.1007\/s12035-012-8291-8","journal-title":"Mol Neurobiol"},{"key":"58_CR93","doi-asserted-by":"publisher","first-page":"845618","DOI":"10.1155\/2012\/845618","volume":"2012","author":"J Blesa","year":"2012","unstructured":"Blesa J, Phani S, Jackson-Lewis V, Przedborski S: Classic and new animal models of Parkinson\u2019s disease. J Biomed Biotechnol 2012, 2012: 845618.","journal-title":"J Biomed Biotechnol"},{"key":"58_CR94","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1111\/j.1742-4658.2012.08491.x","volume":"279","author":"F Blandini","year":"2012","unstructured":"Blandini F, Armentero MT: Animal models of Parkinson\u2019s disease. Febs J 2012, 279: 1156-1166. 10.1111\/j.1742-4658.2012.08491.x","journal-title":"Febs J"},{"key":"58_CR95","first-page":"310","volume":"309","author":"JW Langston","year":"1983","unstructured":"Langston JW, Ballard PA Jr: Parkinson\u2019s disease in a chemist working with 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine. N Engl J Med 1983, 309: 310.","journal-title":"N Engl J Med"},{"key":"58_CR96","first-page":"325","volume":"310","author":"JM Wright","year":"1984","unstructured":"Wright JM, Wall RA, Perry TL, Paty DW: Chronic parkinsonism secondary to intranasal administration of a product of meperidine-analogue synthesis. N Engl J Med 1984, 310: 325.","journal-title":"N Engl J Med"},{"key":"58_CR97","first-page":"781","volume":"14","author":"ML Boatell","year":"1992","unstructured":"Boatell ML, Mahy N, Cardozo A, Ambrosio S, Tolosa E, Cruz-Sanchez FF: Neuronal changes in the nigrostriatal pathway of 1-methyl-4-phenylpyridine-treated mice. Methods Find Exp Clin Pharmacol 1992, 14: 781-787.","journal-title":"Methods Find Exp Clin Pharmacol"},{"key":"58_CR98","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1038\/nn1265","volume":"7","author":"GU Hoeglinger","year":"2004","unstructured":"Hoeglinger GU, Rizk P, Muriel MP, Duyckaerts C, Oertel WH, Caille I, Hirsch EC: Dopamine depletion impairs precursor cell proliferation in Parkinson disease. Nat Neurosci 2004, 7: 726-735. 10.1038\/nn1265","journal-title":"Nat Neurosci"},{"key":"58_CR99","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.neuroscience.2011.10.057","volume":"211","author":"J Bove","year":"2012","unstructured":"Bove J, Perier C: Neurotoxin-based models of Parkinson\u2019s disease. Neuroscience 2012, 211: 51-76.","journal-title":"Neuroscience"},{"key":"58_CR100","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.molbrainres.2005.01.012","volume":"134","author":"M Shimoji","year":"2005","unstructured":"Shimoji M, Zhang L, Mandir AS, Dawson VL, Dawson TM: Absence of inclusion body formation in the MPTP mouse model of Parkinson\u2019s disease. Brain Res Mol Brain Res 2005, 134: 103-108. 10.1016\/j.molbrainres.2005.01.012","journal-title":"Brain Res Mol Brain Res"},{"key":"58_CR101","first-page":"421","volume":"5","author":"U Ungerstedt","year":"1974","unstructured":"Ungerstedt U, Ljungberg T, Steg G: Behavioral, physiological, and neurochemical changes after 6-hydroxydopamine-induced degeneration of the nigro-striatal dopamine neurons. Adv Neurol 1974, 5: 421-426.","journal-title":"Adv Neurol"},{"key":"58_CR102","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/0006-8993(70)90187-3","volume":"24","author":"U Ungerstedt","year":"1970","unstructured":"Ungerstedt U, Arbuthnott GW: Quantitative recording of rotational behavior in rats after 6-hydroxy-dopamine lesions of the nigrostriatal dopamine system. Brain Res 1970, 24: 485-493. 10.1016\/0006-8993(70)90187-3","journal-title":"Brain Res"},{"key":"58_CR103","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1074\/jbc.C100560200","volume":"277","author":"AB Manning-Bog","year":"2002","unstructured":"Manning-Bog AB, McCormack AL, Li J, Uversky VN, Fink AL, Di Monte DA: The herbicide paraquat causes up-regulation and aggregation of alpha-synuclein in mice: paraquat and alpha-synuclein. J Biol Chem 2002, 277: 1641-1644. 10.1074\/jbc.C100560200","journal-title":"J Biol Chem"},{"key":"58_CR104","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1038\/81834","volume":"3","author":"R Betarbet","year":"2000","unstructured":"Betarbet R, Sherer TB, MacKenzie G, Garcia-Osuna M, Panov AV, Greenamyre JT: Chronic systemic pesticide exposure reproduces features of Parkinson\u2019s disease. Nat Neurosci 2000, 3: 1301-1306. 10.1038\/81834","journal-title":"Nat Neurosci"},{"key":"58_CR105","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/S0166-4328(02)00180-8","volume":"136","author":"M Alam","year":"2002","unstructured":"Alam M, Schmidt WJ: Rotenone destroys dopaminergic neurons and induces parkinsonian symptoms in rats. Behav Brain Res 2002, 136: 317-324. 10.1016\/S0166-4328(02)00180-8","journal-title":"Behav Brain Res"},{"key":"58_CR106","doi-asserted-by":"crossref","first-page":"10756","DOI":"10.1523\/JNEUROSCI.23-34-10756.2003","volume":"23","author":"TB Sherer","year":"2003","unstructured":"Sherer TB, Betarbet R, Testa CM, Seo BB, Richardson JR, Kim JH, Miller GW, Yagi T, Matsuno-Yagi A, Greenamyre JT: Mechanism of toxicity in rotenone models of Parkinson\u2019s disease. J Neurosci 2003, 23: 10756-10764.","journal-title":"J Neurosci"},{"key":"58_CR107","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/S1474-4422(03)00501-5","volume":"2","author":"DA Di Monte","year":"2003","unstructured":"Di Monte DA: The environment and Parkinson\u2019s disease: is the nigrostriatal system preferentially targeted by neurotoxins? Lancet Neurol 2003, 2: 531-538. 10.1016\/S1474-4422(03)00501-5","journal-title":"Lancet Neurol"},{"key":"58_CR108","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1111\/j.1471-4159.2006.04440.x","volume":"101","author":"M Inden","year":"2007","unstructured":"Inden M, Kitamura Y, Takeuchi H, Yanagida T, Takata K, Kobayashi Y, Taniguchi T, Yoshimoto K, Kaneko M, Okuma Y, Taira T, Ariga H, Shimohama S: Neurodegeneration of mouse nigrostriatal dopaminergic system induced by repeated oral administration of rotenone is prevented by 4-phenylbutyrate, a chemical chaperone. J Neurochem 2007, 101: 1491-1504. 10.1111\/j.1471-4159.2006.04440.x","journal-title":"J Neurochem"},{"key":"58_CR109","doi-asserted-by":"publisher","first-page":"e8762","DOI":"10.1371\/journal.pone.0008762","volume":"5","author":"F Pan-Montojo","year":"2010","unstructured":"Pan-Montojo F, Anichtchik O, Dening Y, Knels L, Pursche S, Jung R, Jackson S, Gille G, Spillantini MG, Reichmann H, Funk RH: Progression of Parkinson\u2019s disease pathology is reproduced by intragastric administration of rotenone in mice. PLoS One 2010, 5: e8762. 10.1371\/journal.pone.0008762","journal-title":"PLoS One"},{"key":"58_CR110","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S0006-8993(97)00008-5","volume":"753","author":"RJ Ferrante","year":"1997","unstructured":"Ferrante RJ, Schulz JB, Kowall NW, Beal MF: Systemic administration of rotenone produces selective damage in the striatum and globus pallidus, but not in the substantia nigra. Brain Res 1997, 753: 157-162. 10.1016\/S0006-8993(97)00008-5","journal-title":"Brain Res"},{"key":"58_CR111","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1046\/j.1471-4159.2003.01533.x","volume":"84","author":"GU Hoeglinger","year":"2003","unstructured":"Hoeglinger GU, Feger J, Prigent A, Michel PP, Parain K, Champy P, Ruberg M, Oertel WH, Hirsch EC: Chronic systemic complex I inhibition induces a hypokinetic multisystem degeneration in rats. J Neurochem 2003, 84: 491-502. 10.1046\/j.1471-4159.2003.01533.x","journal-title":"J Neurochem"},{"key":"58_CR112","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1038\/srep00898","volume":"2","author":"F Pan-Montojo","year":"2012","unstructured":"Pan-Montojo F, Schwarz M, Winkler C, Arnhold M, O\u2019Sullivan GA, Pal A, Said J, Marsico G, Verbavatz JM, Rodrigo-Angulo M, Gille G, Funk RH, Reichmann H: Environmental toxins trigger PD-like progression via increased alpha-synuclein release from enteric neurons in mice. Sci Reports 2012, 2: 898.","journal-title":"Sci Reports"},{"key":"58_CR113","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1007\/s00401-013-1114-9","volume":"125","author":"J Wagner","year":"2013","unstructured":"Wagner J, Ryazanov S, Leonov A, Levin J, Shi S, Schmidt F, Prix C, Pan-Montojo F, Bertsch U, Mitteregger-Kretzschmar G, Geissen M, Eiden M, Leidel F, Hirschberger T, Deeg AA, Krauth JJ, Zinth W, Tavan P, Pilger J, Zweckstetter M, Frank T, Bahr M, Weishaupt JH, Uhr M, Urlaub H, Teichmann U, Samwer M, Botzel K, Groschup M, Kretzschmar H, et al.: Anle138b: a novel oligomer modulator for disease-modifying therapy of neurodegenerative diseases such as prion and Parkinson's disease. Acta Neuropathologica 2013, 125: 795-813. 10.1007\/s00401-013-1114-9","journal-title":"Acta Neuropathologica"},{"key":"58_CR114","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/S0014-5793(01)02597-2","volume":"500","author":"VN Uversky","year":"2001","unstructured":"Uversky VN, Li J, Fink AL: Pesticides directly accelerate the rate of alpha-synuclein fibril formation: a possible factor in Parkinson's disease. FEBS Lett 2001, 500: 105-108. 10.1016\/S0014-5793(01)02597-2","journal-title":"FEBS Lett"},{"key":"58_CR115","doi-asserted-by":"publisher","first-page":"44284","DOI":"10.1074\/jbc.M105343200","volume":"276","author":"VN Uversky","year":"2001","unstructured":"Uversky VN, Li J, Fink AL: Metal-triggered structural transformations, aggregation, and fibrillation of human alpha-synuclein. A possible molecular NK between Parkinson\u2019s disease and heavy metal exposure. J Biol Chem 2001, 276: 44284-44296. 10.1074\/jbc.M105343200","journal-title":"J Biol Chem"},{"key":"58_CR116","doi-asserted-by":"publisher","first-page":"34696","DOI":"10.1074\/jbc.M802210200","volume":"283","author":"AP Chou","year":"2008","unstructured":"Chou AP, Maidment N, Klintenberg R, Casida JE, Li S, Fitzmaurice AG, Fernagut PO, Mortazavi F, Chesselet MF, Bronstein JM: Ziram causes dopaminergic cell damage by inhibiting E1 ligase of the proteasome. J Biol Chem 2008, 283: 34696-34703. 10.1074\/jbc.M802210200","journal-title":"J Biol Chem"},{"key":"58_CR117","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.taap.2006.09.016","volume":"219","author":"G Giordano","year":"2007","unstructured":"Giordano G, Afsharinejad Z, Guizzetti M, Vitalone A, Kavanagh TJ, Costa LG: Organophosphorus insecticides chlorpyrifos and diazinon and oxidative stress in neuronal cells in a genetic model of glutathione deficiency. Toxicol Appl Pharmacol 2007, 219: 181-189. 10.1016\/j.taap.2006.09.016","journal-title":"Toxicol Appl Pharmacol"},{"key":"58_CR118","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1093\/toxsci\/kfi334","volume":"88","author":"RA Schuh","year":"2005","unstructured":"Schuh RA, Kristian T, Gupta RK, Flaws JA, Fiskum G: Methoxychlor inhibits brain mitochondrial respiration and increases hydrogen peroxide production and CREB phosphorylation. Toxicol Sci 2005, 88: 495-504. 10.1093\/toxsci\/kfi334","journal-title":"Toxicol Sci"},{"key":"58_CR119","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.toxlet.2003.10.023","volume":"147","author":"SM Jenkins","year":"2004","unstructured":"Jenkins SM, Barone S: The neurotoxicant trimethyltin induces apoptosis via caspase activation, p38 protein kinase, and oxidative stress in PC12 cells. Toxicol Lett 2004, 147: 63-72. 10.1016\/j.toxlet.2003.10.023","journal-title":"Toxicol Lett"},{"key":"58_CR120","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/j.neuro.2006.07.009","volume":"27","author":"LM Domico","year":"2006","unstructured":"Domico LM, Zeevalk GD, Bernard LP, Cooper KR: Acute neurotoxic effects of mancozeb and maneb in mesencephalic neuronal cultures are associated with mitochondrial dysfunction. Neurotoxicology 2006, 27: 816-825. 10.1016\/j.neuro.2006.07.009","journal-title":"Neurotoxicology"},{"key":"58_CR121","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/0006-8993(95)00509-O","volume":"690","author":"F Monnet-Tschudi","year":"1995","unstructured":"Monnet-Tschudi F, Zurich MG, Pithon E, van Melle G, Honegger P: Microglial responsiveness as a sensitive marker for trimethyltin (TMT) neurotoxicity. Brain Res 1995, 690: 8-14. 10.1016\/0006-8993(95)00509-O","journal-title":"Brain Res"},{"key":"58_CR122","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/S0006-8993(96)00895-5","volume":"741","author":"F Monnet-Tschudi","year":"1996","unstructured":"Monnet-Tschudi F, Zurich MG, Honegger P: Comparison of the developmental effects of two mercury compounds on glial cells and neurons in aggregate cultures of rat telencephalon. Brain Res 1996, 741: 52-59. 10.1016\/S0006-8993(96)00895-5","journal-title":"Brain Res"},{"key":"58_CR123","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1016\/S0140-6736(89)92366-0","volume":"1","author":"AH Schapira","year":"1989","unstructured":"Schapira AH, Cooper JM, Dexter D, Jenner P, Clark JB, Marsden CD: Mitochondrial complex I deficiency in Parkinson\u2019s disease. Lancet 1989, 1: 1269.","journal-title":"Lancet"},{"key":"58_CR124","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1002\/ana.410260606","volume":"26","author":"WD Parker Jr","year":"1989","unstructured":"Parker WD Jr, Boyson SJ, Parks JK: Abnormalities of the electron transport chain in idiopathic Parkinson\u2019s disease. Ann Neurol 1989, 26: 719-723. 10.1002\/ana.410260606","journal-title":"Ann Neurol"},{"key":"58_CR125","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1002\/ana.410370604","volume":"37","author":"RH Haas","year":"1995","unstructured":"Haas RH, Nasirian F, Nakano K, Ward D, Pay M, Hill R, Shults CW: Low platelet mitochondrial complex I and complex II\/III activity in early untreated Parkinson\u2019s disease. Ann Neurol 1995, 37: 714-722. 10.1002\/ana.410370604","journal-title":"Ann Neurol"},{"key":"58_CR126","first-page":"486","volume":"68","author":"I Rybakowska","year":"2011","unstructured":"Rybakowska I, Szreder G, Kaletha K, Barwina M, Waldman W, Sein Anand J: [Reactive oxygen species and 3,4-dihydroxyphenylacetaldehyde in pathogenesis of Parkinson disease]. Przegl Lek 2011, 68: 486-487.","journal-title":"Przegl Lek"},{"key":"58_CR127","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1042\/BJ20111451","volume":"441","author":"J Lee","year":"2012","unstructured":"Lee J, Giordano S, Zhang J: Autophagy, mitochondria and oxidative stress: cross-talk and redox signalling. Biochem J 2012, 441: 523-540. 10.1042\/BJ20111451","journal-title":"Biochem J"},{"key":"58_CR128","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/nm1746","volume":"14","author":"JY Li","year":"2008","unstructured":"Li JY, Englund E, Holton JL, Soulet D, Hagell P, Lees AJ, Lashley T, Quinn NP, Rehncrona S, Bjorklund A, Widner H, Revesz T, Lindvall O, Brundin P: Lewy bodies in grafted neurons in subjects with Parkinson\u2019s disease suggest host-to-graft disease propagation. Nat Med 2008, 14: 501-503. 10.1038\/nm1746","journal-title":"Nat Med"},{"key":"58_CR129","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1038\/nrn2477","volume":"9","author":"P Brundin","year":"2008","unstructured":"Brundin P, Li JY, Holton JL, Lindvall O, Revesz T: Research in motion: the enigma of Parkinson\u2019s disease pathology spread. Nat Rev Neurosci 2008, 9: 741-745. 10.1038\/nrn2477","journal-title":"Nat Rev Neurosci"},{"key":"58_CR130","doi-asserted-by":"publisher","first-page":"13010","DOI":"10.1073\/pnas.0903691106","volume":"106","author":"P Desplats","year":"2009","unstructured":"Desplats P, Lee HJ, Bae EJ, Patrick C, Rockenstein E, Crews L, Spencer B, Masliah E, Lee SJ: Inclusion formation and neuronal cell death through neuron-to-neuron transmission of alpha-synuclein. Proc Natl Acad Sci U S A 2009, 106: 13010-13015. 10.1073\/pnas.0903691106","journal-title":"Proc Natl Acad Sci U S A"},{"key":"58_CR131","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.nbd.2011.01.029","volume":"42","author":"L Alvarez-Erviti","year":"2011","unstructured":"Alvarez-Erviti L, Seow Y, Schapira AH, Gardiner C, Sargent IL, Wood MJ, Cooper JM: Lysosomal dysfunction increases exosome-mediated alpha-synuclein release and transmission. Neurobiol Dis 2011, 42: 360-367. 10.1016\/j.nbd.2011.01.029","journal-title":"Neurobiol Dis"},{"key":"58_CR132","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1212\/WNL.38.8.1285","volume":"38","author":"PL McGeer","year":"1988","unstructured":"McGeer PL, Itagaki S, Boyes BE, McGeer EG: Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson\u2019s and Alzheimer\u2019s disease brains. Neurology 1988, 38: 1285-1291. 10.1212\/WNL.38.8.1285","journal-title":"Neurology"},{"issue":"Suppl 1","key":"58_CR133","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1016\/j.parkreldis.2004.01.005","volume":"10","author":"PL McGeer","year":"2004","unstructured":"McGeer PL, McGeer EG: Inflammation and neurodegeneration in Parkinson\u2019s disease. Parkinsonism Relat Disord 2004, 10(Suppl 1):S3-S7.","journal-title":"Parkinsonism Relat Disord"},{"key":"58_CR134","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/0304-3940(94)90684-X","volume":"172","author":"G Boka","year":"1994","unstructured":"Boka G, Anglade P, Wallach D, Javoy-Agid F, Agid Y, Hirsch EC: Immunocytochemical analysis of tumor necrosis factor and its receptors in Parkinson\u2019s disease. Neurosci Lett 1994, 172: 151-154. 10.1016\/0304-3940(94)90684-X","journal-title":"Neurosci Lett"},{"issue":"Suppl 3","key":"58_CR135","doi-asserted-by":"publisher","first-page":"S49","DOI":"10.1002\/ana.10481","volume":"53","author":"S Hunot","year":"2003","unstructured":"Hunot S, Hirsch EC: Neuroinflammatory processes in Parkinson\u2019s disease. Ann Neurol 2003, 53(Suppl 3):S49-S58. discussion S58-60","journal-title":"Ann Neurol"},{"key":"58_CR136","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1523\/JNEUROSCI.23-04-01228.2003","volume":"23","author":"HM Gao","year":"2003","unstructured":"Gao HM, Hong JS, Zhang W, Liu B: Synergistic dopaminergic neurotoxicity of the pesticide rotenone and inflammogen lipopolysaccharide: relevance to the etiology of Parkinson\u2019s disease. J Neurosci 2003, 23: 1228-1236.","journal-title":"J Neurosci"},{"key":"58_CR137","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1128\/IAI.59.1.181-191.1991","volume":"59","author":"S Kohbata","year":"1991","unstructured":"Kohbata S, Beaman BL: L-dopa-responsive movement disorder caused by Nocardia asteroides localized in the brains of mice. Infect Immun 1991, 59: 181-191.","journal-title":"Infect Immun"},{"key":"58_CR138","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1046\/j.1471-4159.2002.00928.x","volume":"81","author":"HM Gao","year":"2002","unstructured":"Gao HM, Jiang J, Wilson B, Zhang W, Hong JS, Liu B: Microglial activation-mediated delayed and progressive degeneration of rat nigral dopaminergic neurons: relevance to Parkinson\u2019s disease. J Neurochem 2002, 81: 1285-1297. 10.1046\/j.1471-4159.2002.00928.x","journal-title":"J Neurochem"},{"key":"58_CR139","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1111\/j.1472-8206.2008.00616.x","volume":"22","author":"G Dutta","year":"2008","unstructured":"Dutta G, Zhang P, Liu B: The lipopolysaccharide Parkinson\u2019s disease animal model: mechanistic studies and drug discovery. Fundam Clin Pharmacol 2008, 22: 453-464. 10.1111\/j.1472-8206.2008.00616.x","journal-title":"Fundam Clin Pharmacol"},{"key":"58_CR140","doi-asserted-by":"crossref","first-page":"3440","DOI":"10.1523\/JNEUROSCI.19-09-03440.1999","volume":"19","author":"S Hunot","year":"1999","unstructured":"Hunot S, Dugas N, Faucheux B, Hartmann A, Tardieu M, Debre P, Agid Y, Dugas B, Hirsch EC: FcepsilonRII\/CD23 is expressed in Parkinson\u2019s disease and induces, in vitro, production of nitric oxide and tumor necrosis factor-alpha in glial cells. J Neurosci 1999, 19: 3440-3447.","journal-title":"J Neurosci"},{"key":"58_CR141","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2174\/092986708783330665","volume":"15","author":"CH Wong","year":"2008","unstructured":"Wong CH, Crack PJ: Modulation of neuro-inflammation and vascular response by oxidative stress following cerebral ischemia-reperfusion injury. Curr Med Chem 2008, 15: 1-14. 10.2174\/092986708783330665","journal-title":"Curr Med Chem"},{"key":"58_CR142","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.expneurol.2008.04.008","volume":"212","author":"PL McGeer","year":"2008","unstructured":"McGeer PL, McGeer EG: The alpha-synuclein burden hypothesis of Parkinson disease and its relationship to Alzheimer disease. Exp Neurol 2008, 212: 235-238. 10.1016\/j.expneurol.2008.04.008","journal-title":"Exp Neurol"},{"key":"58_CR143","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1289\/ehp.1003013","volume":"119","author":"HM Gao","year":"2011","unstructured":"Gao HM, Zhang F, Zhou H, Kam W, Wilson B, Hong JS: Neuroinflammation and alpha-synuclein dysfunction potentiate each other, driving chronic progression of neurodegeneration in a mouse model of Parkinson\u2019s disease. Environ Health Perspect 2011, 119: 807-814. 10.1289\/ehp.1003013","journal-title":"Environ Health Perspect"},{"key":"58_CR144","first-page":"693761","volume":"2011","author":"AR Esteves","year":"2011","unstructured":"Esteves AR, Arduino DM, Silva DF, Oliveira CR, Cardoso SM: Mitochondrial dysfunction: The road to alpha-synuclein oligomerization in PD. Parkinsons Dis 2011, 2011: 693761.","journal-title":"Parkinsons Dis"},{"key":"58_CR145","doi-asserted-by":"publisher","first-page":"e62143","DOI":"10.1371\/journal.pone.0062143","volume":"8","author":"D Freeman","year":"2013","unstructured":"Freeman D, Cedillos R, Choyke S, Lukic Z, McGuire K, Marvin S, Burrage AM, Sudholt S, Rana A, O\u2019Connor C, Wiethoff CM, Campbell EM: Alpha-synuclein induces lysosomal rupture and cathepsin dependent reactive oxygen species following endocytosis. PLoS One 2013, 8: e62143. 10.1371\/journal.pone.0062143","journal-title":"PLoS One"},{"key":"58_CR146","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.neulet.2010.09.061","volume":"486","author":"SJ Chinta","year":"2010","unstructured":"Chinta SJ, Mallajosyula JK, Rane A, Andersen JK: Mitochondrial alpha-synuclein accumulation impairs complex I function in dopaminergic neurons and results in increased mitophagy in vivo. Neurosci Lett 2010, 486: 235-239. 10.1016\/j.neulet.2010.09.061","journal-title":"Neurosci Lett"},{"key":"58_CR147","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1007\/s12640-013-9420-5","volume":"25","author":"N Braidy","year":"2014","unstructured":"Braidy N, Gai WP, Xu YH, Sachdev P, Guillemin GJ, Jiang XM, Ballard JW, Horan MP, Fang ZM, Chong BH, Chan DK: Alpha-synuclein transmission and mitochondrial toxicity in primary human foetal enteric neurons in vitro. Neurotox Res 2014, 25: 170-182. 10.1007\/s12640-013-9420-5","journal-title":"Neurotox Res"},{"key":"58_CR148","doi-asserted-by":"publisher","first-page":"2000","DOI":"10.1096\/fj.06-6183com","volume":"20","author":"A Klegeris","year":"2006","unstructured":"Klegeris A, Giasson BI, Zhang H, Maguire J, Pelech S, McGeer PL: Alpha-synuclein and its disease-causing mutants induce ICAM-1 and IL-6 in human astrocytes and astrocytoma cells. FASEB J 2006, 20: 2000-2008. 10.1096\/fj.06-6183com","journal-title":"FASEB J"},{"key":"58_CR149","doi-asserted-by":"publisher","first-page":"7687","DOI":"10.1523\/JNEUROSCI.0143-07.2008","volume":"28","author":"HM Gao","year":"2008","unstructured":"Gao HM, Kotzbauer PT, Uryu K, Leight S, Trojanowski JQ, Lee VM: Neuroinflammation and oxidation\/nitration of alpha-synuclein linked to dopaminergic neurodegeneration. J Neurosci 2008, 28: 7687-7698. 10.1523\/JNEUROSCI.0143-07.2008","journal-title":"J Neurosci"},{"key":"58_CR150","doi-asserted-by":"publisher","first-page":"10825","DOI":"10.1523\/JNEUROSCI.3001-08.2008","volume":"28","author":"TC Frank-Cannon","year":"2008","unstructured":"Frank-Cannon TC, Tran T, Ruhn KA, Martinez TN, Hong J, Marvin M, Hartley M, Trevino I, O\u2019Brien DE, Casey B, Goldberg MS, Tansey MG: Parkin deficiency increases vulnerability to inflammation-related nigral degeneration. J Neurosci 2008, 28: 10825-10834. 10.1523\/JNEUROSCI.3001-08.2008","journal-title":"J Neurosci"},{"key":"58_CR151","doi-asserted-by":"publisher","first-page":"658","DOI":"10.2353\/ajpath.2007.060359","volume":"170","author":"EH Norris","year":"2007","unstructured":"Norris EH, Uryu K, Leight S, Giasson BI, Trojanowski JQ, Lee VM: Pesticide exposure exacerbates alpha-synucleinopathy in an A53T transgenic mouse model. Am J Pathol 2007, 170: 658-666. 10.2353\/ajpath.2007.060359","journal-title":"Am J Pathol"},{"key":"58_CR152","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.1523\/JNEUROSCI.23-08-03095.2003","volume":"23","author":"AB Manning-Bog","year":"2003","unstructured":"Manning-Bog AB, McCormack AL, Purisai MG, Bolin LM, Di Monte DA: Alpha-synuclein overexpression protects against paraquat-induced neurodegeneration. J Neurosci 2003, 23: 3095-3099.","journal-title":"J Neurosci"},{"key":"58_CR153","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1016\/j.freeradbiomed.2009.08.003","volume":"47","author":"PJ Kahle","year":"2009","unstructured":"Kahle PJ, Waak J, Gasser T: DJ-1 and prevention of oxidative stress in Parkinson\u2019s disease and other age-related disorders. Free Radic Biol Med 2009, 47: 1354-1361. 10.1016\/j.freeradbiomed.2009.08.003","journal-title":"Free Radic Biol Med"},{"key":"58_CR154","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.4161\/epi.25865","volume":"8","author":"E Masliah","year":"2013","unstructured":"Masliah E, Dumaop W, Galasko D, Desplats P: Distinctive patterns of DNA methylation associated with Parkinson disease: identification of concordant epigenetic changes in brain and peripheral blood leukocytes. Epigenetics 2013, 8: 1030-1038. 10.4161\/epi.25865","journal-title":"Epigenetics"},{"key":"58_CR155","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.ymgme.2013.07.012","volume":"110","author":"V Iacobazzi","year":"2013","unstructured":"Iacobazzi V, Castegna A, Infantino V, Andria G: Mitochondrial DNA methylation as a next-generation biomarker and diagnostic tool. Mol Genet Metab 2013, 110: 25-34. 10.1016\/j.ymgme.2013.07.012","journal-title":"Mol Genet Metab"},{"key":"58_CR156","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1007\/978-94-007-4525-4_22","volume":"61","author":"S Marques","year":"2013","unstructured":"Marques S, Outeiro TF: Epigenetics in Parkinson\u2019s and Alzheimer\u2019s diseases. Sub-cellular biochemistry 2013, 61: 507-525. 10.1007\/978-94-007-4525-4_22","journal-title":"Sub-cellular biochemistry"},{"key":"58_CR157","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.pharmthera.2013.05.010","volume":"140","author":"IF Harrison","year":"2013","unstructured":"Harrison IF, Dexter DT: Epigenetic targeting of histone deacetylase: therapeutic potential in Parkinson\u2019s disease? Pharmacol Ther 2013, 140: 34-52. 10.1016\/j.pharmthera.2013.05.010","journal-title":"Pharmacol Ther"},{"key":"58_CR158","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1038\/nature11060","volume":"485","author":"JM Nussbaum","year":"2012","unstructured":"Nussbaum JM, Schilling S, Cynis H, Silva A, Swanson E, Wangsanut T, Tayler K, Wiltgen B, Hatami A, Ronicke R, Reymann K, Hutter-Paier B, Alexandru A, Jagla W, Graubner S, Glabe CG, Demuth HU, Bloom GS: Prion-like behaviour and tau-dependent cytotoxicity of pyroglutamylated amyloid-beta. Nature 2012, 485: 651-655. 10.1038\/nature11060","journal-title":"Nature"}],"container-title":["Translational Neurodegeneration"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/2047-9158-3-10.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,19]],"date-time":"2020-08-19T07:35:22Z","timestamp":1597822522000},"score":1,"resource":{"primary":{"URL":"https:\/\/translationalneurodegeneration.biomedcentral.com\/articles\/10.1186\/2047-9158-3-10"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5,9]]},"references-count":158,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["58"],"URL":"https:\/\/doi.org\/10.1186\/2047-9158-3-10","relation":{},"ISSN":["2047-9158"],"issn-type":[{"value":"2047-9158","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,5,9]]},"assertion":[{"value":"3 February 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"10"}}